Oxford BioDynamics’ (OBD) “House Stock” Rating Reaffirmed at Shore Capital

Shore Capital reaffirmed their house stock rating on shares of Oxford BioDynamics (LON:OBDGet Rating) in a research note published on Tuesday morning, MarketBeat.com reports.

Oxford BioDynamics Price Performance

Shares of OBD opened at GBX 14.24 ($0.18) on Tuesday. The company has a current ratio of 2.98, a quick ratio of 2.80 and a debt-to-equity ratio of 99.34. Oxford BioDynamics has a 1 year low of GBX 10.98 ($0.14) and a 1 year high of GBX 33 ($0.41). The stock has a market cap of £20.89 million and a P/E ratio of -1.90. The stock’s 50-day moving average price is GBX 18.11 and its two-hundred day moving average price is GBX 16.09.

Insiders Place Their Bets

In other Oxford BioDynamics news, insider Stephen Charles Diggle acquired 50,000 shares of the business’s stock in a transaction dated Friday, November 11th. The shares were acquired at an average price of GBX 18 ($0.22) per share, for a total transaction of £9,000 ($11,142.75).

Oxford BioDynamics Company Profile

(Get Rating)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment.

Read More

Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.